Rivercell 融资2500万美元构建AI虚拟细胞
Rivercell 完成 2500 万美元种子轮融资,由 HV 领投,HCVC、Alven 和 Bpifrance Digital Venture 参投。资金将用于建设数据平台、扩建巴黎湿实验室,并启动其 AI Virtual Cell 计划——公司称之为预测细胞对药物和基因变化反应的“细胞世界模型”。Rivercell 表示现有数据不足,因此计划自行生成数据:拍摄每次实验中的活细胞并读取其基因活动,再由模型挑选下一步实验,同时自研相关仪器。
如果细胞世界模型成立,可能减少药物研发所需的物理实验次数,但公司尚未公布估值或首个模型的时间表。

Paris start-up Rivercell has raised a $25M seed round to build an AI model that predicts how human cells respond to drugs and genetic changes. HV led the round, with HCVC, Alven and Bpifrance Digital Venture taking part, the company said on Wednesday.
The money will pay for Rivercell’s data platform, a bigger wet lab in Paris and the launch of its AI Virtual Cell programme. The company describes the model as a world model of the cell, meaning a simulation that predicts how a cell will change after a treatment.
#Rivercell#HV#HCVC#Alven#Bpifrance Digital Venture#AlphaFold#Bioptimus#Cardiologs